Member access

4-Traders Homepage  >  Shares  >  OTC Bulletin Board  >  IntelGenx Technologies Corp.    IGX   US45822R1014

 SummaryNewsCalendarCompanyFinancialsRevisions 
Company
IntelGenx Technologies Corp. operates as a drug delivery company.It focuses on the development of novel, orally administered drug delivery products based on its proprietary oral drug delivery technologies.The company is a provider of product development services for the pharmaceutical industry,... 
Sector
Pharmaceuticals
Calendar
04/01Earnings Release
More about the company
Financials ($)
Sales 2011 6,00 M
EBIT 2011 -0,10 M
Net income 2011 -0,10 M
Debt 2011 -
Yield 2011 -
Sales 2012 0,97 M
EBIT 2012 -1,88 M
Net income 2012 -2,14 M
Debt 2012 -
Yield 2012 -
PER 2011 30,65
PER 2012
Capi. / Sales 2011 6,48x
Capi. / Sales 2012 40,3x
Capitalization 38,9 M
More Financials
Latest news on INTELGENX TECHNOLOGIES COR
01/12 INTELGENX TECHNOLOGIES : 2015-01-05 IntelGenx to Present at the 8th Annual OneMe..
01/05 IntelGenx to Present at the 8th Annual OneMedForum
01/05 IntelGenx to Present at the 8th Annual OneMedForum
2014 IntelGenx Grants Stock Options
2014 IntelGenx Grants Extension of Marketing Exclusivity in the U.S. to Edgemont o..
2014 INTELGENX TECHNOLOGIES : 2014-12-01 IntelGenx and RedHill Biopharma Announce Acc..
2014 INTELGENX TECHNOLOGIES : 2014-11-26 IntelGenx Announces Update to Settlement of ..
2014 IIROC Trade Resumption - IntelGenx Corp.
More news
Sector news Generic Pharmaceuticals
05:14p NOVARTIS : announces study in NEJM showing Jakavi® was superior to standard ther..
05:05p SALIX PHARMACEUTICALS : Pharma to restate past seven quarters' results
05:01p NOVARTIS : announces study in NEJM showing Jakavi® was superior to standard ther..
Plus d'actualités du secteur Generic Pharmaceuticals
Comments 
Advertisement
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF